Source: https://www.butlersnow.com/attorney/michael-hewes/
Timestamp: 2019-04-24 18:03:20+00:00

Document:
Michael is an experienced litigator who practices in the firm’s Pharmaceutical, Medical Device and Healthcare Group. He has spent the majority of his career defending clients in the pharmaceutical, medical device and biologics industry. Michael also served as a JAG Officer in the Army National Guard where he presided as a judicial advisor.
Michael has litigated all manners of pharmaceutical, biologic and medical device cases throughout the United States, most recently serving as Trial Counsel and Co-National Counsel in a mass tort pharmaceutical action. He has developed expertise in preparing and defending company witnesses at deposition and trial, and has published and spoken on this topic nationally. He has served on numerous trial teams, including Jackson v. McNeil Consumer Healthcare, Case No. ATL-L-880-13, Superior Court of New Jersey, Atlantic County, named one of CVN’s Top 2015 Defense Verdicts.
Michael is a graduate of the International Association of Defense Counsel (IADC) Trial Academy, has been recognized by The Best Lawyers in America® and Mid-South Super Lawyers®, and he is AV® -Preeminent™ Peer Review Rated by Martindale-Hubbell®. He is a graduate of Leadership Mississippi and Leadership Pine Belt. He is involved in a number of industry organizations, including DRI’s Drug and Medical Device Committee and International Association of Defense Counsel. He routinely writes and speaks on issues pertaining to drug and medical device litigation. He also authored The Tempestuous Trial of Maybelline Meriweather, a work of children’s fiction published by River Road Press in 2018, as well as his first novel, Watermark, published by Samntoff Press in 2016.
Michael retired from the Mississippi Army National Guard in 2009 with the rank of Lieutenant Colonel (MS). While in the National Guard, Michael served as trial counsel for both enlisted and officers and presided as judicial advisor on military separation boards.
​In Re Tylenol (Acetaminophen) Marketing, Sales Practices, and Product Liability Litigation (E.D. P.A) (2016).
​Regina Jackson v. Johnson & Johnson et al., New Jersey trial involving Tylenol and liver injury (2015).
Hutto v. McNeil, et al., Louisiana trial involving acetaminophen overdose (2010).
Thomas Gaines v. Johnson & Johnson, et al., California trial involving Children’s Motrin and Stevens-Johnson syndrome (2010).
Karen Robinson v. Johnson & Johnson, et al., Illinois trial involving Children’s Motrin and Stevens-Johnson syndrome (2009).
Stephanie Zundel v Johnson & Johnson, et al., New Jersey trial involving Children’s Motrin and Stevens-Johnson syndrome (2009).
Sabrina Brierton Johnson v. Johnson & Johnson, et al., California trial involving first product liability case in connection with Children’s Motrin and Stevens-Johnson syndrome (2008).
Cona v. Merck & Co., Inc.; New Jersey trial involving Vioxx (2006).
John McDarby v. Merck & Co., Inc.; New Jersey trial involving Vioxx (2006).
Albright v. Merck & Co., Inc.; Alabama trial involving Vioxx (2006).
Humeston v. Merck & Co., Inc.; New Jersey trial involving Vioxx (2005).
Author, The Tempestuous Trial of Maybelline Meriweather, (children’s fiction), River Road Press, 2018.
Co-Author, “What We Wish We Knew Ten Years Ago,” Pro Te: Solutio, Vol. 11 No. 1.
​Author, Watermark (novel), Samntoff Press, 2016.
Presenter, “Successfully Defending the Corporate Deposition; Concrete Examples of How to Prepare Witnesses for Reptile Questions,” ACI Drug and Device Conference, 2015.
Presenter, “FDA Strategic Priorities 2014-2018,” Knowledge Congress webcast, 2015.
Author, "Cutting the Head off the Snake: Blunting the Effect of the Reptile Approach during Corporate Depositions," Pro Te: Solutio, Vol. 8 No. 1, 5-17, March 2015.
Author, “Medicare Secondary Payer Act Private Cause of Action: Legitimate Threat, Plaintiffs’ Bluff, or Somewhere in Between?” Pro Te: Solutio, Vol. 6 No. 2, 9-13, May 2013.
Author, “Update: Implementation of the Pediatric Medical Device Safety and Improvement ACT of 2007,” Pro Te: Solutio, Vol. 4 No. 4, pg. 15, November 2011.
Author, “Not Just for Adults Anymore: New Pediatric Considerations for Pre-Market Approval of Medical Devices,” Pro Te: Solutio, Vol. 3 No. 3, 8-11, August 2010.
Co-Author, “Preparing Your Sales Force: Keeping Legal Issues in Mind from Training to Trial Part II,” Pro Te: Solutio, Vol. 2 No. 3, 8-12, July 2009.
Author, “Preparing Your Sales Force: Keeping Legal Issues in Mind from Training to Trial Part I,” Pro Te: Solutio, Vol. 2 No. 2, 14-19, April 2009.
Author, “Medicare Second Payer Act,” Pro Te: Solutio, Vol. 1 No. 1, 12-17, January 2008.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.